Abstract
Introduction

Allospecific CD8
ϩ T lymphocytes, which accumulate in rejecting organ transplants, are a critical component of the effector limb of the rejection response (1) . These cells promote injury and lysis of donor cells through the actions of cytotoxic molecules such as granzyme B and perforin (2) . Moreover, expression of granzyme B and perforin strongly correlates with acute cellular rejection in transplant biopsies (3) (4) (5) , further supporting the critical role of these CD8 ϩ T cell functions in the pathogenesis of rejection. The CD8 ϩ alloreactive T cell recognizes and engages class I antigens, and its effector functions depend on the molecular interaction of the T cell receptor (TCR) 1 with alloantigens expressed on donor cells. Accordingly, the CD8 ϩ T cell response is particularly important in graft rejection when donor and recipient are disparate at MHC class I loci (6) (7) (8) .
In some in vitro systems, cell surface expression of TCR on individual cells is lost after antigen engagement (9) . The loss of TCR from the cell surface impairs the ability of T cells to respond to their cognate antigens by increasing the threshold required for cell activation and to trigger production of cytokines (10) . This process has been best characterized using cloned T cell populations with well-defined antigen specificities (9) . While a role for modulation of TCR expression in regulating immune responsiveness in vivo has been suggested (11), widespread downregulation of TCR expression among T cells in the course of in vivo immune responses has not been well documented.
In a previous study, we characterized the TCR V ␤ repertoire of CD8 ϩ T cells in mouse kidney allografts (12) . Unexpectedly, we found that a substantial proportion of graft-infiltrating CD8 ϩ cells do not express detectable levels of TCR on their cell surfaces. In the present studies, we demonstrate that the CD8 ϩ TCR Ϫ population consists of CD8 ϩ T cells that have downregulated their expression of cell surface TCR proteins. Further, these findings suggest a mechanism through which the alloimmune response may be modulated at the site of inflammation.
Methods
Animals. For the control mouse renal allografts, we transplanted kidneys from [C57BL/6 ϫ 129/sv] by Dr. Beverly Koller (University of North Carolina) (13) . We obtained B6/C-H2bm1/ByJ [bm-1(H-2 b )] mice from Jackson Laboratories. H-Y TCR transgenic mice (14) on a C57BL/6 background were provided by Dr. Barton Haynes (Duke University Medical Center) and were bred in our colony. Transgenic animals were identified by PCR of genomic DNA prepared from tail biopsies. Female transgene-positive and -negative littermates were used as recipients of kidney grafts from male C57BL/6 mice.
Mouse renal transplantation. We performed vascularized kidney transplants in mice as previously described (15) . Briefly, the animals were anesthetized with isoflurane and the donor kidney, ureter, and bladder were harvested en bloc, including the renal artery with a small aortic cuff and the renal vein with a small vena caval cuff. These vascular cuffs were anastomosed to the recipient abdominal aorta and vena cava, respectively, below the level of the native renal vessels. Total ischemic time averaged 35-40 min. The donor and recipient bladders were attached dome to dome. The right native kidney was removed at time of transplant and the left native kidney was removed through a flank incision 4 d later. Overall surgical mortality was ‫ف‬ 40%.
Mouse heart transplants. Heterotopic mouse cardiac allografts were performed as described by Corry et al. (16) with some modifications. Survival of the grafts was determined by direct palpation through the abdominal wall. Graft-infiltrating lymphocytes were isolated and stained as described below.
Isolation of splenocytes and graft-infiltrating lymphocytes. Splenocytes and graft-infiltrating lymphocytes were isolated from transplant recipients using protocols that have been described previously (17) . Cell isolation took place at 3 wk after transplantation, unless otherwise noted. The kidney grafts were minced with razor blades and incubated with 1 mg/ml Type IV collagenase (Sigma Chemical Co., St. Louis, MO) in complete R10 media consisting of RPMI media supplemented with 10% FCS (Gibco-BRL, Gaithersburg, MD), 100 U/ml/ 100 g/ml penicillin/streptomycin (Gibco-BRL), 0.05 mM 2-mercaptoethanol (Gibco-BRL), and 2 mM [L]-glutamine (Gibco-BRL), for 30 min at 37 Њ C. We obtained splenocyte suspensions by disrupting the tissue between sterile glass slides. Suspensions were incubated on ice for 5 min to allow debris to settle. The resulting supernatant was centrifuged at 200 g for 10 min at 4 Њ C to pellet the cells. We then harvested the cells by Ficoll centrifugation (Pharmacia, Uppsala, Sweden), and washed and resuspended them in complete RPMI media. Yields ranged from 2-6 ϫ 10 6 cells per kidney graft and 75-100 ϫ 10 6 cells per spleen. Cytofluorometry and cell sorting. We performed staining for cytofluorometry as previously described (17) . 1-2 ϫ 10 6 /ml cells were washed and resuspended in PBS/2% FCS/0.02% sodium azide and staining was performed in 100-l volumes at 4 Њ C using optimal concentrations of antibodies. In most cases, graft-infiltrating cells from individual allografts were analyzed separately. mAbs were coupled to FITC, phycoerythrin (PE), or biotin by standard methods. Binding of biotinylated mAbs was detected using either streptavidin-PE (Vector Laboratories, Burlingame, CA), streptavidin-cychrome (PharMingen, San Diego, CA), or both. In the case of three-color flow analyses, cells were blocked in normal mouse serum at 37 Њ C for 20 min and washed before antibody incubation. The mAbs used were all purchased from PharMingen, except as noted: RM4-5 (anti-mouse CD4), 53-6.7 (anti-mouse CD8 ␣ ), H57-597 Culture of graft-infiltrating lymphocytes. Graft-infiltrating cells from 3-wk kidney allografts were isolated, stained, and sorted as described above. Sorted cells were washed once with R10 media and resuspended at a concentration of 1 ϫ 10 5 cells/ml. These cells were cultured with irradiated stimulators (1 ϫ 10 6 /ml) in R10 media supplemented with 19 U/ml rIL-2. Cells were harvested at 7-d intervals by Ficoll centrifugation and restimulated in the same manner. Flow cytometry was performed weekly.
Assay for T cell cytotoxicity. T cell cytotoxicity was quantitated by neutral red uptake assay (19) using bone marrow macrophage targets as previously described (17) . Briefly, macrophages were gener- ϩ cells, beginning with effector:target ratios of 5:1. After 18 h incubation at 37 Њ C, 0.03% neutral red dissolved in PBS was added to each well. After 15 min at 37 Њ C, excess neutral red was removed by washing twice with PBS and then cell-associated dye was released from cells by treatment with 0.5 M acetic acid/0.5% SDS. We measured neutral red uptake, attributed to dye ingestion by viable macrophages remaining in the monolayer, spectrophotometrically at a 550-nM wavelength with a Titertek Multiskan Plate Reader (Flow Laboratories, McLean, VA). We calculated lysis calculated as follows:
where OD experimental is the mean absorbance produced by residual viable macrophages after incubation with T cell effectors. OD control is the mean absorbance produced by identically prepared monolayers in the absence of effectors. Assays were performed on cells sorted on three separate occasions.
Production of IFN-␥ by CD8 ϩ T cells. IFN-␥ production by allostimulated CD8
ϩ T cells in cytotoxic T lymphocyte (CTL) assays was assessed using a sandwich ELISA as previously described (20) . The hybridoma cell line R4-6A2 producing mAb to IFN-␥ was obtained from the American Tissue Culture Collection (Rockville, MD) (21). Immulon-2 ELISA plates (Dynatech, Chantilly, VA) were pretreated overnight at 4 Њ C with 10 g/ml solution of this mAb to IFN-␥ in PBS and then blocked with PBS/0.05% Tween/3% BSA (Sigma Chemical Co.). IFN-␥ standards and tissue culture supernatants were plated in triplicate in PBS/0.05% Tween/1% BSA (Sigma Chemical). After washing, bound IFN-␥ was detected with a rabbit anti-mouse IFN-␥ antibody (1.25 g/ml) (20) followed by a peroxidase-conjugated goat anti-rabbit IgG (Sigma Chemical Co.). Both reagents were dissolved in PBS/0.05% Tween and each well was washed four times after each incubation. After addition of o-phenylenediamine (1 mg/ml; Sigma) and 0.003% hydrogen peroxide in citrate buffer pH 5.0, the absorbance at 450 nm of each well was measured at 15 and 30 min using a Titertek Multiskan Plate Reader (Flow Laboratories).
RNA isolation. Total RNA was isolated from sorted cell populations using the guanadinium thiocyanate-phenol-chloroform extraction method (22) . The RNA obtained was resuspended in diethylpyrocarbonate-treated water and stored at Ϫ70ЊC.
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PCR analysis of cytokine and V␤ gene expression in sorted cells. We determined mRNA expression for cytokines using reverse transcriptase-polymerase chain reaction (RT-PCR) (23) . cDNA was generated from the entire RNA preparation using 1 g oligo-dT primer (Promega Biotec, Madison, WI), 300 U MMLV-reverse transcriptase (Gibco-BRL), in 1 ϫ RT buffer containing 3 mM MgCl 2 , 10 mM DTT (Gibco-BRL), 40 U RNAsin (Promega Biotec), and 0.5 mM dATP, dCTP, dGTP, and dTTP (Promega Biotec), incubated at 42ЊC for 60 min. For PCR, we amplified cDNA in a final volume of 50 l containing 1 M of each primer, 3 mM MgCl 2 , 2.5 U Taq Polymerase (Promega Biotec), 50 mM KCl, 10 mM Tris, and 0.25 mM deoxynucleotide mix. PCR conditions were adjusted for each primer pair. In general, conditions were 45 s denaturation at 95ЊC (1 min for V␤ expression), 1 min annealing at 60ЊC, and 90 s (1 min for V␤ expression) extension at 72ЊC. cDNA from both CD8 For analysis of TCR V␤ gene expression, a V␤-specific oligomer and an oligomer downstream from the CB region, which recognizes both CB1 and CB2, were used. The sequences of the specific murine TCR␤V and TCRC primers are shown below and details of the PCR are similar to those described previously for the analysis of human T cell populations (24): V␤2: 5Ј-GCCACACGGGTCACTGATAC-GGAGCTGAGG-3Ј; V␤8: 5Ј-CAAAACACATGGAGGCTGCA-3Ј; V␤14: 5Ј-GACCAATTCATCCTAAGCACGCAGAAGCTG-3Ј; V␤15: 5Ј-ACTGTGAACTCAGCAATCAA-3Ј; CB: 5Ј-GCCAAG-CACACGAGGGTAGCC-3Ј.
Immunofluorescence staining and confocal microscopy. We performed FACS as described above, using FITC-conjugated H57-597 (anti ␣/␤ TCR) and PE-conjugated 53-6.7 (anti-mouse CD8␣) (PharMingen). Sorted cells were washed with PBS, resuspended in R10 media plus 19 U/ml recombinant IL-2 and maintained at 37ЊC, 5% CO 2 overnight. TCR Ϫ cells did not re-express surface TCR after overnight incubation (see Fig. 6 B) . Sorted cells were then washed twice in PBS and resuspended at 1 ϫ 10 5 cells/ml in fresh PBS. Cytospin preparations of sorted cells or T cell lines were prepared using a Cytospin 3 Cytocentrifuge and single-circle, coated Cytoslides (Shandon Lipshaw, Pittsburgh, PA). On average, 75,000-100,000 cells were applied to each slide. Cells were immediately fixed in acetone: methanol (1:1) at Ϫ20ЊC for 5 min. Slides were washed three times in PBS/1%BSA/1% Tween-20 (Sigma Chemical Co.) and blocked with heat-inactivated normal rabbit serum (1:5; Sigma Chemical Co.) at room temperature for 30 min. After washing in PBS/1%BSA/1% Tween-20, cells were stained with F23.1 (anti-V ␤ 8. 
TCR
Ϫ cells, we analyzed expression of other cell surface proteins using three-color cytofluorometry. These results are summarized in Fig. 2 . Consistent with the absence of surface ␣/␤TCR, these cells were also surface CD3 Ϫ (89%). Further, they did not express ␥/␦TCR (98.6%). The CD8 ϩ ␣/␤TCR Ϫ cells were, however, strongly Thy1.2 ϩ and also expressed CD2 and CD5. This phenotypic profile is most consistent with a thymus-derived T cell lineage. ϩ lymphocytes were isolated from mouse kidney allografts and sorted into ␣/␤TCR ϩ and ␣/␤TCR Ϫ populations as described in Methods. RNA was isolated from the individual cell populations and expression of relevant mRNA species was assessed using semiquantitative RT-PCR. PCR products were analyzed on 2% agarose gels. A representative set of ethidium-stained gels is depicted in Fig. 3 . In the CD8 
ϩ population. This result confirms the ␣/␤ TCR lineage of these cells and provides additional evidence suggesting that these cells have downregulated surface expression of TCR proteins. Interestingly, V␤8 expression appeared to predominate in both the surface TCR ϩ and TCR Ϫ populations (Fig. 4) . This is consistent with previous studies demonstrating that V␤8.3 is overexpressed by alloreactive CD8 ϩ cells in this donor-recipient combination (12) .
Subcellular localization of V␤8 in CD8
ϩ TCR Ϫ cells. To determine whether intracellular TCR protein might be present within the TCR Ϫ cells, we performed immunostaining of freshly isolated TCR cells, using F23.1, an mAb that recognizes V␤8 proteins. Stained cells were analyzed by confocal laser scanning microscopy. We used two Listeria monocyto- Figure 
Analysis of ␣/␤TCR expression on CD8
ϩ cells in the kidneys of transplanted mice. This is a representative geographic plot of staining for CD8 (horizontal axis) and ␣/␤TCR (vertical axis). Data are shown for cells infiltrating kidney allografts, 3 wk after transplantation. The percentage of CD8 ϩ cells that express ␣/␤TCR is 56.0%. Fluorescence intensity for both CD8 and ␣/␤TCR is shown on a four-decade log scale. 15,000 cells were analyzed.
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genes-immune CD8 ϩ T cell clones as controls. As a negative control, we used clone 8, a line that exclusively expresses V␤5.2 and as a positive control, we used clone 37, that exclusively expresses V␤8 (25) . Fig. 5 A shows the V␤5.2 ϩ clone 8 stained with F23.1. There is no detectable fluorescence. In contrast, V␤8 ϩ clone 37 cells stained strongly positive (Fig. 5 B) , demonstrating both cell surface and intracellular granular fluorescence that was predominantly perinuclear. Virtually every cell was highly fluorescent. Staining of freshly isolated CD8 
TCR
ϩ cells (12) . The intensity of staining is clearly greater than in the negative control (Fig. 5 A) , but less intense than in the positive control (Fig. 5 B) . As Fig. 5 (Fig. 6 B) . Under similar culture conditions, TCR (Fig. 6 C) , the Ϫ cells infiltrating kidney allografts, using three-color cytofluorometry, as described in Methods. Lymphocytes isolated from kidney allografts 3 wk after transplantation were stained with FITC-anti-CD8, PE-anti-␣/␤TCR and biotinylated antibodies for a number of cell surface proteins. In these panels, histograms were generated for the expression of the relevant cell surface protein (horizontal axis) vs. cell number (vertical axis), after gating on CD8 ϩ ␣/␤TCR Ϫ cells. Fluorescence intensity for each protein is shown on a fourdecade log scale and event number is shown in linear scale. These analyses are representative of data obtained from lymphocytes from six allografts.
number of viable cells had nearly doubled and virtually 100% of cells expressed ␣/␤TCR. To determine whether exposure to alloantigen was required for re-expression of TCR, we cultured CD8 ϩ TCR Ϫ cells with IL-2 plus irradiated, syngeneic splenocytes for 5 d. Cell growth varied in these cultures. In two instances, cell viability was reduced by 60-65%, while on one occasion, cells expanded 4.5-fold. However, in all instances, Ͼ 95% of viable cells cultured in this fashion expressed TCR (Fig. 7) . Thus, allogeneic stimulation is not required for recovery of surface TCR expression in culture.
Allospecific functions of the CD8 ϩ ␣/␤TCR Ϫ graft-infiltrating cell population. To directly examine alloreactivity and function of CD8 ϩ ␣/␤TCR Ϫ graft infiltrating cells, we measured cytotoxicity and IFN-␥ production. As Fig. 8 A shows, the CD8 ). As demonstrated in Fig. 8 B, ϩ cells observed in kidney allografts occurs in the course of other alloimmune responses, we examined the surface phenotypes of cells in long-term mixed lymphocyte cultures (MLC) and of graft-infiltrating cells isolated from cardiac allografts. After 1 and 3 wk of stimulation in the MLC, 
CD8
ϩ responding cells were almost entirely ␣/␤TCR ϩ (89.9 and 98.8%, respectively). The extent of TCR downregulation in cardiac allograft rejection was examined in hearts from bm-1 donors transplanted into C57BL/6 recipients. In this combination across an isolated MHC class I difference, most cardiac allografts survive for many weeks without immunosuppression and thus we could evaluate the infiltrating CD8 ϩ cells at time points after transplant (3 wk) that were equivalent to those we had studied in the kidney grafts. The majority of CD8 ϩ T cells isolated from these cardiac allografts were TCR ϩ (84.8Ϯ 2.4%), in contrast to the bm-1 kidney allografts, in which only 44% of cells were TCR ϩ .
Increased numbers of alloreactive cells in the recipient T cell repertoire does not enhance TCR downregulation.
To further address the issue of antigen engagement in loss of TCR expression, we performed additional experiments in which kidneys from male C57BL/5 mice were transplanted into female H-Y TCR transgenic mice (14). As described above, significant TCR downregulation is not seen in this combination when wild-type females are used (Table I ). In the H-Y transgenic mice, the transgene consists of re-arranged TCR genes from a clone that recognizes H-Y peptides in the context of class I MHC from H-2 b (14) . In female transgenic mice, Ͼ 85% of peripheral CD8 ϩ T cells bear the H-Y-specific TCR (14) and therefore, in this transplant combination, represent antigen-specific, alloreactive cells. When infiltrating lymphocytes were isolated and analyzed for TCR expression, the majority of the CD8 ϩ cells in these H-Y disparate grafts expressed 
TCR
ϩ cells in the transgenic recipients was virtually identical to that seen in H-Y disparate grafts transplanted into nontransgenic females (83.9Ϯ5.6%; P ϭ NS). Therefore, despite substantial skewing of the T cell repertoire toward alloreactive cells in the transgenic mice, TCR downregulation was not enhanced.
Discussion
In this current study, we describe reversible loss of TCR expression on a large number of CD8 ϩ T cells at the site of an ongoing in vivo immune response. In other systems, TCR downregulation occurs after antigen engagement (9) . Thus, the CD8 ϩ TCR Ϫ phenotype might identify allospecific cells that have encountered antigen. The possibility that these may represent antigen-activated cells is supported both by their cytokine profile and their high alloreactivity upon recovery of TCR expression. In other models, decreased cell surface expression of TCR has been correlated with impaired antigen recognition and related immune functions (10, 11, 26) . Downregulation of the TCR-CD3 complex can be induced by exposure to antigen and may be specifically triggered by antigen engagement by the TCR (9, 27) . Thus, downregulation of TCR expression may be a normal adaptive mechanism within the immune system that limits antigen-specific responses.
While the role of antigen engagement in modulating TCR expression has been demonstrated in various in vitro systems, our data suggest that loss of TCR expression on infiltrating cells in kidney grafts is largely antigen independent. For example, while donor and recipient are disparate for both class I and II MHC antigens in our experiments, substantial downregulation of TCR is observed only in the CD8 ϩ graft-infiltrating cell population; the majority of CD4 ϩ cells retain TCR expression. Second, while previous studies have suggested that only a 
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Ϫ cells are removed from the graft and cultured in the presence of alloantigen, TCR expression returns. Thus, alloantigen in the culture environment does not inhibit recovery of TCR expression, nor does it cause an appreciable loss of TCR once expression has been re-acquired. Finally, in our experiments using H-Y TCR transgenic mice, we find no enhancement of TCR downregulation in H-Y-disparate kidney allografts when the majority of graft-infiltrating CD8 ϩ cells bear alloantigen-specific, transgene-encoded TCRs. Accordingly, our data indicate that factors other than TCR engagement mediate this effect.
As TCR downregulation was not seen in long-term MLC or cardiac allografts and the TCR Ϫ phenotype is lost when the cells are removed from the graft, factors that are present or enriched in the microenvironment of a renal allograft may mediate this process. Previous studies have demonstrated biochemical pathways for TCR downregulation that are not antigen dependent and do not require direct stimulation through the TCR. For example, brief exposure to phorbol esters causes downregulation of TCR expression in human T cell lines (29) (30) (31) and reduced TCR expression after PMA exposure is associated with phosphorylation of CD3␥ and CD3␦ (30) . PMA, in the presence of calcium ionophore or PHA, can activate T cells independent of TCR (32) and this activation triggers cytokine gene expression (33) . However, a precise relationship between T cell activation by PMA or other non-TCR-dependent pathways, and downregulation of TCR expression has not been established. Several previous studies have described TCR downregulation in association with tolerance induction. For example, Zanders et al. (27) found that T cell clones could be rendered tolerant through exposure to large concentrations of peptide antigen, and that this state of specific tolerance was associated with loss of CD3 expression from cell surfaces. In the thymus, Schneider et al. have also described downregulation of TCR after exposure to a tolerogenic signal (34) . Downregulation of TCR has also been demonstrated in a model of extrathymic tolerance induction to class I alloantigens using TCR transgenic mice. In that study, the CD8 ϩ population was primarily affected and downregulation of the clonotypic TCR was observed in lymphoid organs (11). In contrast, in our study we find that the loss of TCR expression, while also primarily involving CD8 ϩ cells, occurs only at the site of inflammation: within the kidney allograft. As originally reported by Russell and associates, some mice develop donor-specific tolerance after receiving a kidney allograft with no other immunomodulatory interventions (35) . Furthermore, in contrast to skin and cardiac allografts, which are rejected within 1-2 wk, mouse kidneys transplanted across a complete H-2 mismatch survive for prolonged periods without immunosuppression (15, 17, 35) . Despite their prolonged survival, these grafts develop histological features of rejection and marked reduction in their glomerular filtration rates. As we have previously demonstrated, 1 wk after transplantation, when the acute cellular response is first manifested, most of the CD8 ϩ cells in the graft also express TCR (12) . Only at later time points, 3 wk and beyond, are we able to detect the TCR Ϫ cells. While we have no evidence to directly link our observation of widespread downregulation of TCR expression on graft-infiltrating cells to the prolonged survival of mouse kidney allografts, it is interesting to note that significant numbers of CD8 ϩ TCR Ϫ cells are only seen in long-surviving ( Ͼ 3 wk) allografts.
In summary, we have identified in long-term surviving kidney allografts a sizable proportion of CD8 ϩ T cells that have reversibly lost expression of ␣ / ␤ TCR proteins. While the mechanism for this downregulation is uncertain, our data do not support a major role for antigen engagement and suggest that factors in the microenvironment of the kidney graft play a key role in this process. As the loss of TCR expression is associated with impaired function and responsiveness, this modulation of TCR expression may play a role in negatively regulating the intragraft immune response. 
